These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 35940392)

  • 1. Annexin A5 as a targeting agent for cancer treatment.
    Woodward A; Faria GNF; Harrison RG
    Cancer Lett; 2022 Oct; 547():215857. PubMed ID: 35940392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Annexin A5 as an immune checkpoint inhibitor and tumor-homing molecule for cancer treatment.
    Kang TH; Park JH; Yang A; Park HJ; Lee SE; Kim YS; Jang GY; Farmer E; Lam B; Park YM; Hung CF
    Nat Commun; 2020 Feb; 11(1):1137. PubMed ID: 32111835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracellular annexin A5: functions of phosphatidylserine-binding and two-dimensional crystallization.
    van Genderen HO; Kenis H; Hofstra L; Narula J; Reutelingsperger CP
    Biochim Biophys Acta; 2008 Jun; 1783(6):953-63. PubMed ID: 18334229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Domain IV of Annexin A5 Is Critical for Binding Calcium and Guarantees Its Maximum Binding to the Phosphatidylserine Membrane.
    Wang J; Liu J; Cao Y; Hu M; Hua Z
    Molecules; 2017 Dec; 22(12):. PubMed ID: 29257055
    [No Abstract]   [Full Text] [Related]  

  • 5. Phosphatidylserine externalized on the colonic capillaries as a novel pharmacological target for IBD therapy.
    Zhang X; Song L; Li L; Zhu B; Huo L; Hu Z; Wang X; Wang J; Gao M; Zhang J; Hua Z
    Signal Transduct Target Ther; 2021 Jun; 6(1):235. PubMed ID: 34131110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell surface-expressed phosphatidylserine as therapeutic target to enhance phagocytosis of apoptotic cells.
    Schutters K; Kusters DH; Chatrou ML; Montero-Melendez T; Donners M; Deckers NM; Krysko DV; Vandenabeele P; Perretti M; Schurgers LJ; Reutelingsperger CP
    Cell Death Differ; 2013 Jan; 20(1):49-56. PubMed ID: 22955945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cooperative binding of Annexin A5 to phosphatidylserine on apoptotic cell membranes.
    Janko C; Jeremic I; Biermann M; Chaurio R; Schorn C; Muñoz LE; Herrmann M
    Phys Biol; 2013 Dec; 10(6):065006. PubMed ID: 24304966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Annexin A5 inhibits engulfment through internalization of PS-expressing cell membrane patches.
    Kenis H; van Genderen H; Deckers NM; Lux PA; Hofstra L; Narula J; Reutelingsperger CP
    Exp Cell Res; 2006 Apr; 312(6):719-26. PubMed ID: 16380116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular imaging of cell death in tumors. Increasing annexin A5 size reduces contribution of phosphatidylserine-targeting function to tumor uptake.
    Ungethüm L; Chatrou M; Kusters D; Schurgers L; Reutelingsperger CP
    PLoS One; 2014; 9(5):e96749. PubMed ID: 24801051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purine nucleoside phosphorylase targeted by annexin v to breast cancer vasculature for enzyme prodrug therapy.
    Krais JJ; De Crescenzo O; Harrison RG
    PLoS One; 2013; 8(10):e76403. PubMed ID: 24098491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engineered annexin A5 variants have impaired cell entry for molecular imaging of apoptosis using pretargeting strategies.
    Ungethüm L; Kenis H; Nicolaes GA; Autin L; Stoilova-McPhie S; Reutelingsperger CP
    J Biol Chem; 2011 Jan; 286(3):1903-10. PubMed ID: 21078669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphatidylserine targeting for diagnosis and treatment of human diseases.
    Schutters K; Reutelingsperger C
    Apoptosis; 2010 Sep; 15(9):1072-82. PubMed ID: 20440562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrophage recognition of externalized phosphatidylserine and phagocytosis of apoptotic Jurkat cells--existence of a threshold.
    Borisenko GG; Matsura T; Liu SX; Tyurin VA; Jianfei J; Serinkan FB; Kagan VE
    Arch Biochem Biophys; 2003 May; 413(1):41-52. PubMed ID: 12706340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting phosphatidylserine in anti-cancer therapy.
    Kenis H; Reutelingsperger C
    Curr Pharm Des; 2009; 15(23):2719-23. PubMed ID: 19689342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo evaluation of [99mTc]-labeled tricarbonyl His-annexin A5 as an imaging agent for the detection of phosphatidylserine-expressing cells.
    Vangestel C; Peeters M; Oltenfreiter R; D'Asseler Y; Staelens S; Van Steenkiste M; Philippé J; Kusters D; Reutelingsperger C; Van Damme N; Van de Wiele C
    Nucl Med Biol; 2010 Nov; 37(8):965-75. PubMed ID: 21055628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-circulating XTEN864-annexin A5 fusion protein for phosphatidylserine-related therapeutic applications.
    Haeckel A; Ascher L; Beindorff N; Prasad S; Garczyńska K; Guo J; Schellenberger E
    Apoptosis; 2021 Oct; 26(9-10):534-547. PubMed ID: 34405304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of annexin A5 in the modulation of the immune response against dying and dead cells.
    Munoz LE; Frey B; Pausch F; Baum W; Mueller RB; Brachvogel B; Poschl E; Rödel F; von der Mark K; Herrmann M; Gaipl US
    Curr Med Chem; 2007; 14(3):271-7. PubMed ID: 17305532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Annexin V expression on CD4
    Bollinger AL; Bollinger T; Rupp J; Shima K; Gross N; Padayachy L; Chicheportiche R; Puga Yung GL; Seebach JD
    Immunology; 2020 Feb; 159(2):205-220. PubMed ID: 31642515
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.